Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption.

J Pediatr Hematol Oncol

Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut 06510, USA.

Published: November 1999

Purpose: In 1981, Buchanan and Sheehan described a previously unreported syndrome in three siblings who had iron malabsorption, hypoferremia, and microcytic anemia that did not respond to oral iron and responded only partly to parenteral iron dextran. Ferrokinetic studies were not done in these or subsequently reported patients with this syndrome. It has been postulated that this syndrome of abnormal iron metabolism is analogous to that observed in the mk/mk mouse, which has similar hematologic findings but also has abnormal ferrokinetics. Ferrokinetic studies were performed in one patient to determine whether the abnormality of iron metabolism in the human syndrome is analogous to the mk/mk mouse.

Patients And Methods: Two sisters with severe microcytic anemia and iron malabsorption who have had only partial response to parenteral iron have been followed up for 15 years. Ferrokinetic studies with 59Fe were performed in one sister.

Results: Ferrokinetic studies with radio iron were characteristic of iron deficient erythropoiesis (rapid 59Fe T1/2; rapid, complete incorporation of 59Fe into erythrocyte hemoglobin). These ferrokinetics differ from those of the mk/mk mouse, which has a missense mutation in Nramp2, a putative iron transporter protein. In these children, once iron enters the plasma its subsequent metabolism (including binding to transferrin), transfer into erythroid bone marrow cells, and subsequent incorporation into erythrocyte hemoglobin are all normal. The defect in these patients appears to be an undefined, novel abnormality that governs mobilization of iron into the plasma from both the intestinal mucosal and reticuloendothelial cells. Despite lifelong severe hypoferremia, the growth, development and intellectual performance of these children, who are teen-agers, are normal.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-199909000-00014DOI Listing

Publication Analysis

Top Keywords

ferrokinetic studies
16
iron
13
microcytic anemia
12
iron malabsorption
12
anemia iron
8
parenteral iron
8
iron metabolism
8
mk/mk mouse
8
erythrocyte hemoglobin
8
ferrokinetics syndrome
4

Similar Publications

Assessing Human Iron Kinetics Using Stable Iron Isotopic Techniques.

Clin Pharmacokinet

October 2024

Radcliffe Department of Medicine, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Stable iron isotope techniques are critical for developing strategies to combat iron deficiency anemia, a leading cause of global disability. There are four primary stable iron isotope methods to assess ferrokinetics in humans. (i) The fecal recovery method applies the principles of a metabolic balance study but offers enhanced accuracy because the amount of iron isotope present in feces can be directly traced back to the labeled dose, distinguishing it from endogenous iron lost in stool from shed intestinal cells.

View Article and Find Full Text PDF

Objective: To assess adherence to the recommendations for the diagnosis and management of hospitalized patients with Decompensated Heart Failure issued by the European Society of Cardiology in 2021 at a Coronary Care Unit at a fourth-level hospital in the city of Bogotá.

Materials And Methods: A descriptive cross-sectional study was conducted, including hospitalized patients in the Coronary Care Unit at Hospital San José in Bogotá, with a primary diagnosis of Decompensated Heart Failure, from September 2021 to January 2023. Patient data were collected from medical records.

View Article and Find Full Text PDF
Article Synopsis
  • Iron deficiency (ID) negatively impacts the functional capacity of heart failure patients, even those with preserved ejection fraction (HFpEF), prompting this study to assess how baseline iron levels affect improvements in peak oxygen consumption (peakVO) from exercise therapy.
  • In a trial involving 59 stable HFpEF patients, participants underwent a 12-week physical therapy regimen with varying interventions, while their iron levels were measured to understand their influence on aerobic capacity changes.
  • Results indicated that patients with ID showed less improvement in peakVO compared to those without ID, highlighting the significance of iron status in enhancing exercise outcomes, and pointing towards the need for further research in this area.
View Article and Find Full Text PDF

Anemia is a common complication of chronic kidney disease (CKD) and is associated with a decrease in quality of life and an increased risk of transfusions, morbidity and mortality, and progression of CKD. The Anemia Working Group of the Sociedad Española de Nefrología conducted a Delphi study among experts in anemia in CKD to agree on relevant unanswered questions by existing evidence. The RAND/UCLA consensus methodology was used.

View Article and Find Full Text PDF

Short-Term Changes in Peak VO After Initiation of Dapagliflozin in Heart Failure Across Iron Status.

JACC Heart Fail

November 2023

Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain; INCLIVA, Valencia, Spain; Universitat de València, Valencia, Spain; CIBER Cardiovascular, Madrid, Spain. Electronic address:

Article Synopsis
  • Some studies suggest SGLT2 inhibitors like dapagliflozin can impact how cells use iron, particularly in patients with heart failure and reduced ejection fraction (HFrEF).
  • The study aimed to evaluate the effects of dapagliflozin on iron parameters and peak oxygen consumption (Vo) in HFrEF patients.
  • Results showed dapagliflozin significantly decreased ferritin levels and increased peak Vo at 1 and 3 months, especially in patients with lower baseline iron levels, indicating improved energy efficiency linked to iron use.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!